USPTO serial 79302308
COMVITA LEPTERIDINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 4, 2022
- Examiner
- SANCHEZ RIVERA, MARIA C.
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with COMVITA LEPTERIDINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vitamin and mineral supplements and preparations thereof; dietetic preparations adapted for medical use; honey dietary supplements; nutritional supplements in the form of gummies; throat lozenges; throat lozenges made from honey; medicated preparations or supplements for supporting digestive and skin health in this class made from, or containing honey; Pharmaceutical preparations, namely, herbal elixirs, herbal remedies, herbal extracts for therapeutic and medicinal purposes; honey nutritional and dietary supplements in the form of capsules, liquids, gels, powders and elixirs made from or consisting of honey | ACTIVE | — |
| 030 | Honey; gummy candies made of honey; lollipops; non-medicated confectionery, namely, candy and pastilles; non-medicated lozenges | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Comvita Limited
- Other trademarks owned by Comvita Limited
- Other trademarks owned by Comvita Limited
- Other trademarks in Class 005
- Other trademarks in Class 030
- Similar marks named COMVITA LEPTERIDINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 18, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 18, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 18, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 18, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 18, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 18, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 12, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 22, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 22, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 4, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 4, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 19, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 19, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 29, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 13, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 2, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 16, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 16, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 11, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 10, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2021 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Feb 26, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 25, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 24, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 26, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 22, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 21, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 14, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |